When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression

Will the FDA approve Any psychedelic substance for medical use this year?: Any psychedelic substance for medical use

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?: Before July 2027

When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?: before April 2027

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?: Before October 2027

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?: before November

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?: before October

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?: before September

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?: Before September

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?: before December

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?: before April 2027

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?: before October

When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?: before October

When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?: before December

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?: Before 2028

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?: Before July 2027

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?: before April 2027

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?: before December

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?: Before 2028

When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?: before 2027